近日,平安健康发布2024年财报,取得营收48.1亿元,调整后净利润达到1.58亿元,实现首次年度盈利。这份被资本市场称为“转折之年”的成绩单迅速引发券商密集关注,中信证券、花旗、华创证券、中信建投证券等机构接连发布研报,看好平安健康后市发展,并明确给出“买入”、“推荐”等评级,认为其是长线资金战略配置的优质选择。机构普遍认为,这一里程碑式突破的背后,是平安健康在服务生态重构、AI技术渗透、支付端...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.